The company told the publication it is looking to expand from a 34,000-square-foot facility in New Castle to a 200,000-square-foot location near Newark. Accredo is looking to grow its fulfillment abilities, move shipping operations in-house, and address growth in the biosimilar and gene therapy drug markets.
While a lease for the facility is still under negotiation, the company hopes to have half the facility in operation by the end of next year. In September, the state approved a $4.62 million grant for the project.
